Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 563 entries
View as:

Involving Family to Improve Communication in Breast Cancer Care

Phase: N/A Priority: Normal
NCT ID: NCT03283553 Org: User:
Start: 07/20/17 End: 11/07/19 Due: 11/07/20

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04892303 Org: User:
Start: 03/17/21 End: 12/31/30 Due: 12/31/31

Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT03909464 Org: User:
Start: 11/29/17 End: 11/25/19 Due: 11/25/20

Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00414492 Org: User:
Start: 12/31/06 End: 06/30/10 Due: 06/30/11

177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06322576 Org: User:
Start: 02/10/25 End: 02/28/35 Due: 02/28/36

Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00390403 Org: User:
Start: 02/28/07 End: - Due: -

Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C)

Phase: N/A Priority: Normal
NCT ID: NCT01876511 Org: User:
Start: 09/30/13 End: 08/31/19 Due: 08/31/20

Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03642067 Org: User:
Start: 02/12/19 End: 09/18/24 Due: 09/18/25

Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00290732 Org: User:
Start: 11/30/05 End: 10/31/11 Due: 10/31/12

Pre-Prostatectomy Lovastatin on Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01478828 Org: User:
Start: 07/13/12 End: 04/08/13 Due: 04/08/14

Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05013216 Org: User:
Start: 04/11/22 End: 05/01/26 Due: 05/01/27

Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00616967 Org: User:
Start: 05/31/08 End: 02/28/26 Due: 02/28/27

Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia

Phase: N/A Priority: Normal
NCT ID: NCT00867308 Org: User:
Start: 07/31/09 End: 05/31/14 Due: 05/31/15

Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients

Phase: N/A Priority: Normal
NCT ID: NCT04843306 Org: User:
Start: 06/03/21 End: 08/18/23 Due: 08/18/24

Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01317199 Org: User:
Start: 07/31/11 End: 11/30/15 Due: 11/30/16

A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02111187 Org: User:
Start: 04/30/14 End: 01/18/17 Due: 01/18/18

Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00003961 Org: User:
Start: 04/30/99 End: 12/31/07 Due: 12/31/08

Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03006302 Org: User:
Start: 01/31/18 End: 08/05/24 Due: 08/05/25

Radiotherapy for Solid Tumor Spine Metastases

Phase: N/A Priority: Normal
NCT ID: NCT01752036 Org: User:
Start: 05/20/13 End: 07/27/18 Due: 07/27/19

Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma

Phase: N/A Priority: Normal
NCT ID: NCT02989636 Org: User:
Start: 03/10/17 End: 11/30/26 Due: 11/30/27

Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05025423 Org: User:
Start: 06/21/22 End: 05/14/25 Due: 05/14/26

Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00373191 Org: User:
Start: 05/31/06 End: 12/31/13 Due: 12/31/14

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06059118 Org: User:
Start: 10/04/23 End: 11/30/29 Due: 11/30/30

Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04301778 Org: User:
Start: 08/24/21 End: 02/06/24 Due: 02/06/25

Pembrolizumab in Patients With Leptomeningeal Disease

Phase: N/A Priority: Normal
NCT ID: NCT03091478 Org: User:
Start: 04/12/17 End: 12/14/19 Due: 12/14/20